BioSig Technologies’ $17.5 Million Common Stock Offering


Haynes and Boone represented BioSig Technologies, Inc. in the offering.

BioSig Technologies, Inc. (Nasdaq: BSGM) executed a $17.5 million registered direct offering of its common stock, which closed on June 26, 2020.

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiogram (ECG) and intra-cardiac signals.

Haynes and Boone represented BioSig with a team led by New York Partner Rick Werner (Picture), co-chair of the Capital Markets and Securities Practice Group, and Jayun Koo, a partner in the New York Capital Markets and Securities Practice Group. They were assisted by New York Associate Eloise Rotenberg.

Involved fees earner: Jayun Koo – Haynes and Boone; Eloise Rotenberg – Haynes and Boone; Rick Werner – Haynes and Boone;

Law Firms: Haynes and Boone;

Clients: BioSig Technologies;

Author: Ambrogio Visconti